| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02368951 Details | 2017-07-12 Interventional | 1 | 20 | Aprutumab ixado… Medical Oncolog… | - - | |||
| NCT02099604 Details | 2017-07-12 Interventional | 3 | 0 | Interferon alph… Interferon-alph… Interferons Peginterferon a… Ribavirin Vitamin D Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… Hepatitis, Chro… Chronic Hepatit… | Study objectives were considered as obsolete regarding the new AAD arrival - | |||
| NCT01526837 Details | 2017-07-12 Interventional | 1 | 1 | Bevacizumab Glioblastoma Recurrence Glioblastoma Mu… | Investigators decision - | |||
| NCT01266291 Details | 2017-07-12 Interventional | 4 | 1 | Vigabatrin Seizures Tuberous Sclero… Complex Partial… | Was not possible to enroll sufficient number of subjects to draw any worthwhile conclusions
from the study. The study was terminated due to insufficient enrollment; 98 potentially eligible patients were pre-screened and only one enrolled. The study was not terminated due to concerns regarding safety or efficacy. | |||
| NCT00849875 Details | 2017-07-12 Interventional | 2 | 48 | Dacarbazine Imidazole Melanoma | Early end of trial notification after termination of long term follow up due to lack of
scientific justification to continue collect information. - | |||
| NCT03042013 2016-003183-39 Details | 2017-07-11 Interventional | 2 | 0 | Naquotinib Subjects With N… | Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies. - | |||
| NCT02639819 Details | 2017-07-11 Interventional | 1 | 0 | Aminocaproic Ac… Cerebral Hemorr… Hemorrhage Intracerebral H… | Study was withdrawn from IRB review on 03/08/16 - | |||
| NCT00194792 Details | 2017-07-11 Interventional | 2 | 28 | Capecitabine Exemestane Methotrexate Paclitaxel Triptorelin Pam… Vinorelbine Breast Neoplasm… Estrogen Recept… HER2-negative B… Progesterone Re… Stage I Breast … Stage II Breast… Stage IIIA Brea… | - - | |||
| NCT03211052 Details | 2017-07-07 Interventional | 2 | 16 | Leuprolide Prostatic Neopl… Prostate Cancer | IMP no longer available - | |||
| NCT01712646 Details | 2017-07-07 Interventional | 1/2 | 18 | Oxytocin Psychotic Disor… Schizophrenia Schizophrenia, … Childhood Onset… | - - | |||
| NCT01332552 Details | 2017-07-07 Interventional | 1 | 27 | Ritonavir Hepatitis Hepatitis A Hepatitis C | Terminated due to unfavorable human pharmacokinetic properties - | |||
| NCT00064987 Details | 2017-07-07 Interventional | 2 | 19 | Follicle Stimul… Hormones Hypogonadism Kallmann Syndro… | Recruitment was at a standstill. We are currently preparing our results for publication. - | |||
| NCT00981903 Details | 2017-07-06 Interventional | 2 | 131 | Dalteparin Heparin, Low-Mo… Tinzaparin Thromboembolism Venous Thromboe… Cancer | Tinzaparin will no longer be available in the United States - | |||
| NCT03208361 2012-003511-63 Details | 2017-07-05 Interventional | 3 | 43 | Amoxicillin Penicillin V Penicillins Pneumonia Community-acqui… | Lack of financial support to continue with the study recruitment. Independent study financially
supported by a national grant with a 4.5 years duration. - | |||
| NCT01147601 Details | 2017-07-05 Interventional | 1 | 6 | Timolol Hemangioma Hemangioma, Cap… Port-Wine Stain Infant | - - | |||
| NCT03181880 Details | 2017-07-02 Interventional | 4 | 0 | Bromides Formoterol Fuma… Lung Diseases Lung Diseases, … Pulmonary Disea… Chronic Obstruc… | Study stopped early as AZ have re-prioritised to focus on research to help bring existing and
innovative medicines to more patients with asthma and COPD. - | |||
| NCT02432664 Details | 2017-07-02 Interventional | 1 | 85 | Midazolam Healthy | The study was terminated after the second cohort had completed Part II due complex PK results.
There were no safety concerns. - | |||
| NCT01342887 Details | 2017-07-02 Interventional | 1/2 | 6 | Cyclosporine Cyclosporins Etoposide Etoposide phosp… Mitoxantrone Pravastatin Leukemia Leukemia, Eryth… Leukemia, Megak… Leukemia, Monoc… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Adult Acute Meg… Adult Acute Min… Adult Acute Mon… Adult Acute Mon… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Erythrole… Adult Pure Eryt… Recurrent Adult… | - - | |||
| NCT00925132 Details | 2017-07-02 Interventional | 1/2 | 39 | Decitabine Panobinostat Temozolomide Melanoma Metastatic Mela… | Change in the number of approved drugs for metastatic melanoma This study was closed to enrollment early as there was a change in the number of approved drugs for metastatic melanoma, making Temozolomide as a chemotherapy agent, an unlikely treatment for metastatic melanoma. | |||
| NCT00085410 Details | 2017-07-02 Interventional | 2 | [1 Refs] | 20 | Bortezomib Adenocarcinoma Bile Duct Neopl… Cholangiocarcin… Gallbladder Neo… Gastrointestina… Liver Neoplasms Recurrence Adenocarcinoma … Adenocarcinoma … Advanced Adult … Gastrointestina… Localized Unres… Recurrent Adult… Recurrent Extra… Recurrent Gallb… Unresectable Ex… Unresectable Ga… | The trial was discontinued early due to no confirmed partial responses. The trial was discontinued early due to no confirmed partial responses. |